Both psilocybin (the active compound in magic mushrooms) and MDMA (also known as ecstasy or molly) are currently in Schedule I — the US government's most restricted drug category, reserved for substances with no accepted medical use. Moving a drug out of Schedule I requires a formal scientific recommendation from a government health agency, followed by a lengthy public rulemaking process. Neither of those steps has started, so nothing will change before 2027.
Scheduling requires an HHS scientific recommendation followed by DEA notice-and-comment rulemaking; no such HHS recommendation has been transmitted. Appropriations activity does not trigger rescheduling. DEA enforcement posture remains unchanged.